D
Viking Therapeutics, Inc. VKTX
$22.26 -$1.97-8.11%
Recommendation
Sell
Prev Close
$24.22
Volume
3,103,644
Avg Vol (90D)
4,090,683
Market Cap
$2.72B
Dividend & Yield
--
52-Week Range
$23.27 - $81.86
P/E (TTM)
--
EPS (TTM)
-$1.01
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Which Healthcare Stock Is the Best Buy Right Now?
3/31/2025 - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Director Buys $29,946.00 in Stock
4/3/2025 - MarketBeat
Viking Therapeutics (VKTX, $25.68) RSI Indicator left the oversold zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
The Smartest Biotech Stocks to Buy With $50
4/3/2025 - Fool.com Headlines
Mitsubishi UFJ Asset Management Co. Ltd. Buys New Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
4/3/2025 - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Sets New 12-Month Low - Time to Sell?
4/2/2025 - MarketBeat
Clearbridge Investments LLC Sells 98,456 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)
4/2/2025 - MarketBeat
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
4/2/2025 - Fool.com Headlines
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by DnB Asset Management AS
4/2/2025 - MarketBeat
American Century Companies Inc. Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX)
4/2/2025 - MarketBeat
Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade
4/1/2025 - Zacks Investment Research
Viking Therapeutics (VKTX, $24.15) RSI Indicator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Viking Therapeutics (VKTX, $24.15) price may climb as it broke lower Bollinger Band on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
Traders Purchase High Volume of Call Options on Viking Therapeutics (NASDAQ:VKTX)
3/31/2025 - MarketBeat
Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month
3/31/2025 - Simply Wall St
Viking Therapeutics (NASDAQ:VKTX) Hits New 1-Year Low - Should You Sell?
3/31/2025 - MarketBeat
Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)
3/31/2025 - TipRanks Financial Blog
A Closer Look at Viking Therapeutics's Options Market Dynamics
3/28/2025 - Benzinga
Viking Therapeutics (VKTX, $26.13) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet
3/27/2025 - Zacks Investment Research
VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug
3/27/2025 - Zacks Investment Research
BIT Capital GmbH Has $5.01 Million Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)
3/27/2025 - MarketBeat
Viking Therapeutics (VKTX, $26.34) price may climb as it broke lower Bollinger Band on Mar 26, 2025
3/27/2025 - Tickeron - Technical Analysis
Viking Therapeutics (VKTX, $26.34) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2025
3/27/2025 - Tickeron - Technical Analysis
MarketBeat Week in Review – 03/17 - 03/21
3/22/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$150.92M
Net Income (TTM)
-$109.96M
Balance Sheet
Total Assets (Q)
$908.32M
Total Debt (Q)
$1.12M
Total Liabilities (Q)
$28.04M
Book Value Per Share (Q)
$7.89
Cash Flow
Cash from Operations (TTM)
-$87.79M
Cash from Investing (TTM)
-$553.37M
Cash from Financing (TTM)
$612.46M
Net Change in Cash (TTM)
-$28.84M
Filings
Filing Date
Wednesday, February 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Apr 21 and 25 (est)
Price History
Loading...
Beta
2.22
7-Day Total Return
-15.57%
30-Day Total Return
-34.72%
60-Day Total Return
-46.62%
90-Day Total Return
-56.92%
Year to Date Total Return
-45.91%
1-Year Total Return
-69.82%
2-Year Total Return
30.44%
3-Year Total Return
606.03%
5-Year Total Return
378.28%
52-week Low
Mar 31, 2025 - $23.27
52-week High
May 07, 2024 - $81.86
Valuation
Market Cap
$2.72B - Mid Cap
Enterprise Value
$1.82B
Price/Sales (TTM)
--
Price/Book (Q)
3.07
Dividends and Shares
Shares Outstanding
111.34M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.vikingtherapeutics.com
Phone Number
858 704 4660
Address
9920 Pacific Heights Boulevard
San Diego, CA 92121
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company’s lead drug candidate is... more
NASDAQ 04/04/2025 12:38PM Eastern Quotes delayed
Weiss Ratings